The cumulative number of authorizations for individual patients in Brazil to import nonregistered medical cannabis products exceeded 13,000 at the end of September 2019, according to data the country’s health regulator shared with Marijuana Business Daily.
Alfredo Pascual
Alfredo Pascual's Latest Posts
Greece’s new government committed to cannabis sector success: Q&A with Pelopidas Kalliris of Ministry of Development and Investment
Greece is one of a half-dozen European countries hoping to cash in on medical cannabis exports. The country is also developing rules for domestic patients to access medical marijuana. Because Greece was among the first countries to allow medical cannabis cultivation...
Analysis: Germany’s medical cannabis market loses momentum but on pace to surpass 100 million euros
Insurance reimbursements for medical cannabis in Germany reached a new high during the July-September period, according to recently published data by the German National Association of Statutory Health Insurance Funds (GKV-Spitzenverband). [include_post...
Italy to nearly triple domestic medical cannabis production in 2020
The Italian Ministry of Health plans to almost triple the quantity of medical marijuana to be produced domestically in the coming year. This signals the intention of the government to rely to a lesser degree on imports in 2020 to serve growing domestic demand for...
Aurora details why it temporarily halted German medical cannabis sales
Aurora Cannabis was forced to stop sales of medical marijuana in Germany over “a form of treatment that we use to maintain the product without microbial contamination,” Cam Battley, the Alberta, Canada, company’s chief corporate officer, said at Marijuana Business Daily’s Investor Intelligence Conference.
Peru issues key cannabis regulations, effectively launching nation’s medical marijuana program
Peruvian authorities have published long-awaited guidelines governing the nation's medical marijuana program, allowing companies to start applying for different types of business licenses spelled out under a 2017 law. The new regulations mark the effective launch of...
Brazilian court decision could encourage other cannabis companies to seek approval for cultivation
After Brazil's health authority shelved a proposal on domestic cannabis cultivation this week, a court decided in the opposite direction, allowing – for the first time in Brazil – a company to grow hemp commercially. The court's decision could spur other cannabis...
German court confirms CBD without ‘novel’ designation can’t be sold as food
The Gießen Administrative Court (VG Gießen) ruled that local authorities in Germany were right to not permit sales of CBD products that don’t have a “novel food” authorization.
Brazil’s new medical cannabis rules reject domestic cultivation, potentially setting up large import market
Brazilian health authorities rejected domestic cultivation of medical marijuana but agreed to permit the distribution of medicinal cannabis products that have not completed clinical trials, potentially setting up one of the largest import markets in the world. The new...
Aurora Cannabis products unavailable in Germany until further notice
Aurora Cannabis' medical marijuana products are temporarily unavailable in Germany pending a review by health authorities of "a proprietary step" in the Alberta company's production process, a spokesperson confirmed to Marijuana Business Daily. MJBizDaily corroborated...
What businesses need to know about exporting irradiated medical cannabis to Germany
By now, everyone knows that to export medical cannabis to Germany, which is by far the largest importer of medical cannabis flower in the world, achieving European Union Good Manufacturing Practice (GMP) is a prerequisite. But beyond getting that certification,...
Cyprus delays bidding process so medical cannabis licensing fees can be reviewed
The bidding process to cultivate medical cannabis in Cyprus is stalled after government authorities requested a review of the licensing fees. The delay, reported by the Phileleftheros newspaper, stemmed from concerns the fees are too low given the revenue growers are...












